Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: A Hoosier Oncology Group randomized study

N. H. Hanna, A. B. Sandler, P. J. Loehrer, R. Ansari, S. H. Jung, K. Lane, L. H. Einhorn

Research output: Contribution to journalArticle

49 Scopus citations

Fingerprint Dive into the research topics of 'Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: A Hoosier Oncology Group randomized study'. Together they form a unique fingerprint.

Medicine & Life Sciences